Home > Boards > US OTC > Medical - Drugs >

RXI Pharmaceuticals Corp (RXII)

RXII RSS Feed 		Add RXII Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Croireavenir, Armani, starbuxsux, zoriden, Inoviorulez
Search This Board:
Last Post: 5/17/2013 12:47:07 PM - Followers: 43 - Board type: Free - Posts Today: 0

About RXi Pharmaceuticals

RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform.  Therapeutics that use RNA interference, or "RNAi," have great promise because of their ability to "silence," or down-regulate, the expression of a specific gene that may be overexpressed in a disease condition.  Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, RXi's first RNAi product candidate, RXI-109, entered into RXi's first human clinical trial in 2012.  RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation, and is initially being developed to reduce or inhibit scar formation in the skin following surgery.



RXi Pharmaceuticals Corp., has received patent approval for their new experimental breast cancer vaccine which became part of the company's arsenal after acquiring Apthera Inc. in April of this year.
The specific patents in question regard using the vaccine NeuVax with the drug Herceptin which is used in women to slow the production of the HER2 protein in tumors, while NeuVax attempts to make the body's immune system fight off cancerous cells.
According to The Telegram:
"The patents also cover using NeuVax in patients not eligible for Herceptin treatment."
With their patent in place the company plans to begin human tests in early 2012.
According to RXi the patents were developed by Dr. George E. Peoples, director of the Cancer Vaccine Development Program for the U.S. Military Cancer Institute and RXi is leasing the patents for their own work.



This May, RXi Pharmaceuticals Corp. observed two momentous events: The biotechnology company completed its spinoff from Galena Biopharma Inc., and Dr. Geert Cauwenbergh took the helm as president and chief executive officer. The small company's first product, an anti-scarring medication called RXI-109, entered clinical trials this year, and is based on the pioneering work in RNA interference of RXi scientific founder and Nobel Laureate Dr. Craig C. Mello. Dr. Cauwenbergh came to RXi after a long career in pharmaceuticals, most recently as president and chief executive officer of a company he founded, Barrier Therapeutics. What attracted you to come to Worcester? "It was the technology, well, the technology and the chemistry with these people. They're very bright." As a publicly traded company, how do you reconcile the needs of the investors, which are sometimes a short-term desire for profits, with the needs of medical research, which sometimes takes years? "Through business development. Basically what you do as a small biotech is you try to create a big network with people who have interest in various stages of development. ... In two or three years they get antsy and they want to cash in, but at that point in time there will be and there is already a network of business development contacts in place where you can for instance get nondiluted money without having to raise money and go back to the stock market and shareholders by making regional deals or geographic deals ...

Press Releases
RXi Pharmaceuticals to Present at Biotech Showcase™ 2013 - December 19, 2012
RXi Pharmaceuticals Announces Initiation of Second Double-Blind Vehicle Controlled Phase 1 Study With Its Anti-Scarring Compound, RXI-109 - December 5, 2012
RXi Pharmaceuticals Announces Pharmacokinetic Results of its Single Dose Phase 1 Study with RXI-109 in Healthy Volunteers - November 15, 2012
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2012 - November 14, 2012
RXi Pharmaceuticals to Present at 12th Annual Biotech Symposium - October 16, 2012
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology - October 4, 2012
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum - October 2, 2012
RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program - September 24, 2012
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2012 - August 15, 2012
RXi Pharmaceuticals Appoints Jeannette Graf MD and Leroy Young MD to its Scientific Advisory Board - July 13, 2012
 

Share Statistics
Avg Vol (3 month)3: 215,443
Avg Vol (10 day)3: 145,371
Shares Outstanding5: 158.67M
Float: 53.34M
% Held by Insiders1: 9.01%
% Held by Institutions1: 0.50%
 



http://www.rxipharma.com/

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RXII
Current Price
Volume:
Bid Ask Day's Range
RXII Detailed Quote Wiki
RXII News: VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial Results 05/09/2013 04:05:00 PM
RXII News: RXi Pharmaceuticals to Present at the 2013 ARVO Annual Meeting 04/30/2013 07:02:00 AM
RXII News: RXi Pharmaceuticals Announces Investor and Analyst Symposium 04/29/2013 07:02:00 AM
RXII News: RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors 04/22/2013 07:05:00 AM
RXII News: RXi Pharmaceuticals Reports Full Year 2012 Financial Results 03/29/2013 07:15:00 AM
PostSubject
#462  Sticky Note RXi Pharmaceuticals: Realizing RNA’s Revolutionary Potential starbuxsux 04/26/13 12:04:35 PM
#442  Sticky Note I will post this here for new investors Inoviorulez 04/19/13 09:52:48 PM
#518   More important than that.. IMO... He took 50 now invest 05/17/13 12:47:07 PM
#517   I agree on that.Frost would not give there zoriden 05/17/13 12:33:22 PM
#516   You know... I really like that FROST has now invest 05/17/13 09:21:07 AM
#515   Blue Horseshoe loves RXII :) acediego 05/16/13 12:46:09 AM
#514   Looking real good.Especially with the 0 side effects.Amazing. zoriden 05/15/13 07:04:27 PM
#513   no webcast but it is under resources and Inoviorulez 05/15/13 06:19:24 PM
#512   I went to RXI website and did not zoriden 05/15/13 05:03:17 PM
#511   RXi Pharmaceuticals Reports Financial Results for the First starbuxsux 05/15/13 03:05:07 PM
#510   Nice thanks zoriden 05/15/13 11:49:12 AM
#509   It's from a press release, but the conference Inoviorulez 05/15/13 11:17:18 AM
#508   Thanks, Where did you find they are zoriden 05/15/13 11:12:15 AM
#507   I doubt it , I think it's just Inoviorulez 05/15/13 11:01:36 AM
#506   Is that on unblinded stage 1 trials? zoriden 05/15/13 10:58:35 AM
#505   Presentation out today at 4:15 p.m est time. Inoviorulez 05/15/13 10:00:09 AM
#504   Earnings out... and we just broke .20... ask now invest 05/15/13 09:41:52 AM
#503   funny how LAFC shows 5000 on the now invest 05/14/13 03:04:28 PM
#502   We need more volume tomorrow, hopefully would be Inoviorulez 05/13/13 11:26:53 PM
#501   Looks like some are hitting and hitting the now invest 05/13/13 12:35:33 PM
#500   Hmmm... bids starting to come in at .195.... now invest 05/13/13 10:52:51 AM
#499   Thanks for the post... zoriden 05/09/13 06:31:53 PM
#498   Poster Presentation for today May 9th, 2013 is Inoviorulez 05/09/13 05:22:15 PM
#497   Thanks for clarifying! PharmaInsider 05/09/13 08:43:20 AM
#496   RXi Pharmaceuticals to Present at IBC's 15th Annual starbuxsux 05/09/13 07:47:44 AM
#495   Oh, I see, I didn't know about the Catalyst_Fun 05/08/13 07:06:11 PM
#494   The reason why people are confused is because Inoviorulez 05/08/13 07:04:25 PM
#493   Phase 1 will be released in Q2 2013, Catalyst_Fun 05/08/13 04:11:39 PM
#492   I've been looking around for a while, but PharmaInsider 05/08/13 03:28:21 PM
#491   Yes...Those guys got paid awhile ago, when they headshrink3 05/08/13 03:02:10 PM
#490   From the information you quote, it appears that Steuvin 05/07/13 09:27:51 AM
#489   New insider filings for RXII: RXi Pharmaceuticals Corp zoriden 05/06/13 09:28:24 PM
#488   There have been a ton of sells- RXII Cobra Kai 05/06/13 07:52:45 PM
#487   Where did you find that, I could not poogs99 05/06/13 07:38:01 PM
#486   2 directors bought 1 million shares each today zoriden 05/06/13 06:31:40 PM
#485   Cool, thanks for the link! GALE is taking Catalyst_Fun 05/03/13 05:14:53 PM
#484   Good news they have like 34 million more mik3 05/03/13 04:13:19 PM
#483   How much more does Gale own at this point? BeckK 05/03/13 02:46:35 PM
#482   MAYBE GALE NEEDS CASH? zoriden 05/03/13 01:36:28 PM
#481   It is Gale just got a call from zoriden 05/03/13 01:35:07 PM
#480   Can't help but think that Gale is responsible mik3 05/03/13 12:45:50 PM
#479   I added as well...The long term of RXII zoriden 05/01/13 01:39:08 PM
#478   I'm buying more, typical huge drop before 2 Inoviorulez 05/01/13 01:11:48 PM
#477   wow touched on 17 cents- is this seller Cobra Kai 05/01/13 12:54:55 PM
#476   Those presentations at ARVO should help give the Inoviorulez 04/30/13 09:06:15 AM
#475   RXi Pharmaceuticals to Present at the 2013 ARVO starbuxsux 04/30/13 07:50:22 AM
#474   Yah I saw that press release this morning, Inoviorulez 04/29/13 08:14:12 AM
#473   WESTBOROUGH, Mass.--(BUSINESS WIRE)-- now invest 04/29/13 07:36:33 AM
#472   Yeah I could see it working if there poogs99 04/27/13 05:04:45 PM
#471   Agree... zoriden 04/27/13 03:04:06 PM
#470   I agree...But it's not done yet.I do not zoriden 04/27/13 03:00:14 PM
#469   I understand that there are risks here. Nevertheless, Steuvin 04/27/13 12:54:06 PM
PostSubject